Global pharmaceutical giant Johnson & Johnson (J&J) has announced the establishment of a Global Capability Center (GCC) in Hyderabad, India, marking a significant milestone in the city’s emergence as a hub for life sciences and healthcare innovation.
Location and Focus
The new GCC is situated at RMZ Nexity in HITEC City and operates under J&J’s Innovative Medicine division. The center is designed to support the company’s operations in:
- Research and Development (R&D)
- Digital Innovation
- Data Analytics
- Business Transformation
This initiative underscores Hyderabad’s growing importance as a destination for global pharmaceutical and biotech companies.
Recruitment and Operations
While an official statement from Johnson & Johnson is awaited, job postings in Hyderabad indicate a robust recruitment drive across technology, regulatory, and R&D functions. Reports suggest the GCC is already operational, with phased onboarding of teams planned.
Hyderabad’s Life Sciences Ecosystem
Johnson & Johnson joins a growing roster of international life sciences firms with operations in Hyderabad, including Novartis, Sanofi, Bristol Myers Squibb, Roche, and AstraZeneca. This reinforces the city’s reputation as a global hub for pharmaceutical innovation and healthcare R&D.
Strategic Significance
The establishment of J&J’s GCC in Hyderabad reflects a strategic focus on leveraging India’s talent pool, advanced digital capabilities, and cost-effective operations. It also highlights Hyderabad’s position as a key location for companies aiming to scale global operations in healthcare and life sciences.
Visit Our News section and follow us on LinkedIn and Twitter
Read more full news: Here
